Fibroblast Growth Factor 11 (FGF11) Promotes Progression and Cisplatin Resistance Through the HIF-1α/FGF11 Signaling Axis in Ovarian Clear Cell Carcinoma

BACKGROUND: A poor prognosis is often associated with ovarian clear cell carcinoma (OCCC) due to its relative resistance to platinum-based chemotherapy. Although several studies have been launched to explore the pathogenesis of OCCC, the mechanism of chemoresistance has yet to be uncovered. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Min, Lu, Chunli, Zhou, Huimei, Liu, Qian, Yang, Jiaxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387280/
https://www.ncbi.nlm.nih.gov/pubmed/37525667
http://dx.doi.org/10.2147/CMAR.S414703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387280/
https://www.ncbi.nlm.nih.gov/pubmed/37525667
http://dx.doi.org/10.2147/CMAR.S414703

Ejemplares similares